These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29778106)

  • 1. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
    Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Findl O; Murta JCN; Goslings WRO; Tassignon MJ; Joosse MV; Henry YP; Rulo AHF; Güell JL; Amon M; Kohnen T; Nuijts RMMA;
    J Cataract Refract Surg; 2018 Apr; 44(4):429-439. PubMed ID: 29778106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C; Salsini G; Perri P
    Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
    Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Murta JCN; Goslings WRO; Kohnen T; Tassignon MJ; Joosse MV; Henry YP; Nagy ZZ; Rulo AHF; Findl O; Amon M; Nuijts RMMA;
    J Cataract Refract Surg; 2018 Jul; 44(7):836-847. PubMed ID: 30055692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
    Song SH; Baek SK; Lee MW; Lee YH
    Korean J Ophthalmol; 2020 Feb; 34(1):46-55. PubMed ID: 32037749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
    Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
    Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
    Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
    Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
    Cardascia N; Palmisano C; Centoducati T; Alessio G
    Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.
    Kim S; Kim MK; Wee WR
    Korean J Ophthalmol; 2017 Oct; 31(5):394-401. PubMed ID: 28913997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination.
    Ylinen P; Holmström E; Laine I; Lindholm JM; Tuuminen R
    Acta Ophthalmol; 2018 Aug; 96(5):486-493. PubMed ID: 29369527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of prevention of cystoid macular edema after cataract surgery in patients without diabetes: ESCRS PREMED study report 4.
    Simons RWP; Wielders LHP; Dirksen CD; Veldhuizen CA; van den Biggelaar FJHM; Winkens B; Schouten JSAG; Nuijts RMMA;
    J Cataract Refract Surg; 2021 Mar; 47(3):331-339. PubMed ID: 33009281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study.
    Pinna A; Blasetti F; Ricci GD; Boscia F
    Eur J Ophthalmol; 2017 May; 27(3):326-330. PubMed ID: 28009414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K; Ota I; Miyake G; Numaga J
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
    Kitazawa K; Kayukawa K; Wakimasu K; Inatomi T; Hieda O; Mori K; Sotozono C; Kinoshita S
    Jpn J Ophthalmol; 2018 Nov; 62(6):615-620. PubMed ID: 30255396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
    Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
    J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG; Lira RP; Zanetti FR; Machado MC; Rodrigues GB; Arieta CE
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
    Shimura M; Nakazawa T; Yasuda K; Nishida K
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):284-91. PubMed ID: 17593013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
    Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
    Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.